FR2813531B1 - Formes galeniques d'oligoelements incorpores dans un excipient biologiquement actif d'homogenat d'oeufs de caille et leur procede de fabrication - Google Patents

Formes galeniques d'oligoelements incorpores dans un excipient biologiquement actif d'homogenat d'oeufs de caille et leur procede de fabrication

Info

Publication number
FR2813531B1
FR2813531B1 FR0011354A FR0011354A FR2813531B1 FR 2813531 B1 FR2813531 B1 FR 2813531B1 FR 0011354 A FR0011354 A FR 0011354A FR 0011354 A FR0011354 A FR 0011354A FR 2813531 B1 FR2813531 B1 FR 2813531B1
Authority
FR
France
Prior art keywords
oligoelements
homogenate
incorporated
manufacturing
biologically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0011354A
Other languages
English (en)
Other versions
FR2813531A1 (fr
Inventor
Georges Bruttmann
Dit Bon Michel Betend
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medibrevex
Original Assignee
Medibrevex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medibrevex filed Critical Medibrevex
Priority to FR0011354A priority Critical patent/FR2813531B1/fr
Publication of FR2813531A1 publication Critical patent/FR2813531A1/fr
Application granted granted Critical
Publication of FR2813531B1 publication Critical patent/FR2813531B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FR0011354A 2000-09-06 2000-09-06 Formes galeniques d'oligoelements incorpores dans un excipient biologiquement actif d'homogenat d'oeufs de caille et leur procede de fabrication Expired - Fee Related FR2813531B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0011354A FR2813531B1 (fr) 2000-09-06 2000-09-06 Formes galeniques d'oligoelements incorpores dans un excipient biologiquement actif d'homogenat d'oeufs de caille et leur procede de fabrication

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0011354A FR2813531B1 (fr) 2000-09-06 2000-09-06 Formes galeniques d'oligoelements incorpores dans un excipient biologiquement actif d'homogenat d'oeufs de caille et leur procede de fabrication

Publications (2)

Publication Number Publication Date
FR2813531A1 FR2813531A1 (fr) 2002-03-08
FR2813531B1 true FR2813531B1 (fr) 2003-02-14

Family

ID=8854018

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0011354A Expired - Fee Related FR2813531B1 (fr) 2000-09-06 2000-09-06 Formes galeniques d'oligoelements incorpores dans un excipient biologiquement actif d'homogenat d'oeufs de caille et leur procede de fabrication

Country Status (1)

Country Link
FR (1) FR2813531B1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE20300304U1 (de) * 2003-01-09 2003-04-24 Dr. Gerhard Mann Chem.-pharm. Fabrik GmbH, 13581 Berlin Ocuvite Zink
FR2901137B1 (fr) * 2006-05-19 2013-01-25 Dit Bon Michel Betend Nouvelles formes galeniques d'inhibiteurs naturels des enzymes proteasiques, extraits d'oeuf de caille, associes a des vitamines ou/et a des mineraux, acides amines incorpores dans un excipient.
BE1020496A3 (fr) 2012-02-10 2013-11-05 Ovogenics Sa Composition anti-inflammatoire pour moduler la reponse cellulaire des neutrophiles et des eosinophiles.
BE1026978B1 (fr) 2019-01-23 2020-08-24 Pascal Melsens Procede de production d'ovomucoïdes et d'ovoinhibiteurs a partir d'un lot d'œufs de caille coturnix coturnix japonica

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2356426A1 (fr) * 1976-06-29 1978-01-27 Truffier Jean Claude Fraction ovomucoide du blanc de l'oeuf de caille, ayant des proprietes antiproteasiques
FR2624013B2 (fr) * 1987-10-08 1991-07-12 Medibrevex Application comme medicaments utiles pour le traitement allopathique des maladies allergiques de formes galeniques d'oeufs de caille
FR2731353A1 (fr) * 1995-03-09 1996-09-13 Rigal Dominique Utilisation de l'oeuf de caille ou de ses derives ajoute a un antigene comme adjuvant de l'induction d'une tolerance par voie orale ou aerienne pour le traitement des maladies a composantes immunitaires
FR2740041B3 (fr) * 1995-10-23 1997-09-12 Pental Corp Sa Composition a base d'oeuf de caille, et son usage pharmaceutique ou cosmetique

Also Published As

Publication number Publication date
FR2813531A1 (fr) 2002-03-08

Similar Documents

Publication Publication Date Title
FR2797179B1 (fr) Prothese nucleaire intervertebrale et son procede chirurgical d'implantation
FR2777690B1 (fr) Structure et procede de fabrication d'un condensateur
FR2847155B1 (fr) Procede de fabrication d'un implant medical a structure ajouree et implant obtenu par ce procede
LU91368I2 (fr) Fésotérodine et ses sels avec des acides physiologiquement acceptables y compris l'acide fumarique (TOVIAZ)
FR2798219B1 (fr) Inductance et procede de fabrication
FR2814360B1 (fr) Injecteur d'implant intraoculaire souple
LU91131I2 (fr) Duloxétine et ses sels d'addition acides pharmaceutiquement acceptables, et en particulier, chlorhydrate de duloxétine.
DE69941113D1 (de) Zytokinen und mitogenen um "graft-versus-host disease" zu verhindern
BR9606607A (pt) Composto método de aperfeiçoamento de transporte de uma droga ou outro ativo método de fabricação de um medicamento composto uso método de tratamento de uma doença e método de preparação de um medicamento
ITFI990258A0 (it) Protesi dentale con mezzi per il rilascio di farmaci o fattori specifi ci atti ad impedire l'insorgenza di infezioni e/o promuovere la cresci
FR2794019B1 (fr) Implant d'osteosynthese
FR2813531B1 (fr) Formes galeniques d'oligoelements incorpores dans un excipient biologiquement actif d'homogenat d'oeufs de caille et leur procede de fabrication
PT830132E (pt) Composicao farmaceutica contendo hidrocloruro de tiagabina como ingrediente activo e seu processo de preparacao
FR2789464B1 (fr) Support antivibratoire et son procede de fabrication
FR2629346B1 (fr) Compositions veterinaires synergiquement actives et leur procede de fabrication
IT1314154B1 (it) Struttura a condensatore verticale ad alta densita' di integrazione erelativo processo di fabbricazione
FR2761529B1 (fr) Memoire morte a structure non-et et procede de fabrication
FR2800364B1 (fr) Microcavite active accordable et procede de fabrication de microcavite active accordable
NO307126B1 (no) Anvendelse av biologisk aktive ureidoderivater for fremstilling av et medikament for bruk i behandlingen av lentivirusindusert sykdom
FR2802591B1 (fr) Vilebrequin mecano-soude et son procede de fabrication
FR2818999B1 (fr) Procede de fabrication d'un monument funeraire
FR2805093B1 (fr) Bougie d'allumage et son procede de fabrication
FR2722512B1 (fr) Strucutre d'electrode et son procede de fabrication
ITTO20000536A0 (it) Procedimento per la fabbricazione di componenti di un'ossatura e componenti di ossatura.
FR2792532B1 (fr) Nouvelles compositions antiseptiques et leur procede d'obtention

Legal Events

Date Code Title Description
ST Notification of lapse
RN Application for restoration
D3 Decision to revoke the decision of lapse
PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 18

PLFP Fee payment

Year of fee payment: 19

ST Notification of lapse

Effective date: 20200910